Fluarix Quadrivalent 2021 - 2022 Flu Vaccine 60 mcg / 0.5 mL Indicated For People 6 Months of Age and Above Prefilled Syringe 0.5 mL
- Fluarix is an inactivated influenza vaccine indicated for active immunization against influenza disease caused by influenza virus subtypes A and type B contained in the vaccine
- Fluarix is approved for use in persons 6 months of age and older
- Each 0.5 mL dose is supplied in single-dose prefilled TIP-LOK syringes
- FLUARIX QUADRIVALENT has been standardized according to U.S. Public Health Service (USPHS) requirements for the 2021 - 2022 influenza season and is formulated to contain 60 micrograms (mcg) hemagglutinin (HA) per 0.5-mL dose, in the recommended ratio of 15 mcg HA of each of the following 4 influenza virus strains (2 A strains and 2 B strains): A/Brisbane/02/2018 (H1N1) pdm09 (IVR-190), A/Kansas/14/2017 (H3N2) NYMC X-327, B/Maryland/15/2016 NYMC BX-69A (a B/Colorado/06/2017-like virus), and B/Phuket/3073/2013.
- Strength:
- 60 mcg / 0.5 ml
- Volume:
- 0.5 ml
- Type:
- intramuscular
- Manufacturer #:
- 58160088752
- Brand:
- Fluarix Quadrivalent 2021 - 2022
- Patient type:
- indicated for people 6 months of age and above
- UNSPSC:
- 51201608
- Mckesson #:
- 1182041
- Storage requirements:
- requires refrigeration
- NDC number:
- 58160-0887-52
- Product dating:
- mckesson acceptable dating: we will ship >= 90 days
- Manufacturer:
- Glaxo Smith Kline
- Application:
- flu vaccine
- Dosage form:
- injection
- Container type:
- prefilled syringe
- Supplier:
- McKesson
